Dhananjay Suresh

Dr. Dhananjay Suresh

orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 June 2017 in Scientific Reports
Verified
Journal Article
Open access
PDF file
AJAngela B. Javurek
Angela B. Javurek
DSDhananjay Suresh
Dhananjay Suresh
WSWilliam G. Spollen
William G. Spollen
MHMarcia L. Hart
Marcia L. Hart
SHSarah A. Hansen
Sarah A. Hansen
Cheryl S. RosenfeldCheryl S. Rosenfeld
Cheryl S. Rosenfeld
Due to their antimicrobial properties, silver nanoparticles (AgNPs) are being used in non-edible and edible consumer products. It is not clear though if exposure to these chemicals can exert toxic effects on the host and gut microbiome. Conflicting studies have been reported on whether AgNPs result in gut dysbiosis and other changes within the host. We sought to examine whether exposure of Sprague-Dawley male rats for two weeks to different shapes of AgNPs, cube (AgNC) and sphere (AgNS) affects gut microbiota, select behaviors, and induces histopathological changes in the gastrointestinal system and brain. In the elevated plus maze (EPM), AgNS-exposed rats showed greater number of entries into closed arms and center compared to controls and those exposed to AgNC. AgNS and AgNC treated groups had select reductions in gut microbiota relative to controls. Clostridium spp., Bacteroides uniformis, Christensenellaceae, and Coprococcus eutactus were decreased in AgNC exposed group, whereas, Oscillospira spp., Dehalobacterium spp., Peptococcaeceae, Corynebacterium spp., Aggregatibacter pneumotropica were reduced in AgNS exposed group. Bacterial reductions correlated with select behavioral changes measured in the EPM. No significant histopathological changes were evident in the gastrointestinal system or brain. Findings suggest short-term exposure to AgNS or AgNC can lead to behavioral and gut microbiome changes.

29 July 2014 in Bioconjugate Chemistry
Verified
Journal Article
Closed access
DSDhananjay Suresh
Dhananjay Suresh
AZAjit Zambre
Ajit Zambre
NCNripen Chanda
Nripen Chanda
THTimothy J. Hoffman
Timothy J. Hoffman
CSC. Jeffrey Smith
C. Jeffrey Smith
RKRaghuraman Kannan
Raghuraman Kannan

17 August 2016 in Scientific Reports
Verified
Journal Article
Open access
RSR. Srikar
R. Srikar
DSDhananjay Suresh
Dhananjay Suresh
AZAjit Zambre
Ajit Zambre
KTKristen Taylor
Kristen Taylor
SCSarah Chapman
Sarah Chapman
RKRaghuraman Kannan
Raghuraman Kannan
A tri-block nanoparticle (TBN) comprising of an enzymatically cleavable porous gelatin nanocore encapsulated with gefitinib (tyrosine kinase inhibitor (TKI)) and surface functionalized with cetuximab-siRNA conjugate has been synthesized. Targeted delivery of siRNA to undruggable KRAS mutated non-small cell lung cancer cells would sensitize the cells to TKI drugs and offers an efficient therapy for treating cancer; however, efficient delivery of siRNA and releasing it in cytoplasm remains a major challenge. We have shown TBN can efficiently deliver siRNA to cytoplasm of KRAS mutant H23 Non-Small Cell Lung Cancer (NSCLC) cells for oncogene knockdown; subsequently, sensitizing it to TKI. In the absence of TKI, the nanoparticle showed minimal toxicity suggesting that the cells adapt a parallel GAB1 mediated survival pathway. In H23 cells, activated ERK results in phosphorylation of GAB1 on serine and threonine residues to form GAB1-p85 PI3K complex. In the absence of TKI, knocking down the oncogene dephosphorylated ERK, and negated the complex formation. This event led to tyrosine phosphorylation at Tyr627 domain of GAB1 that regulated EGFR signaling by recruiting SHP2. In the presence of TKI, GAB1-SHP2 dissociation occurs, leading to cell death. The outcome of this study provides a promising platform for treating NSCLC patients harboring KRAS mutation.

10 August 2016 in Archives of Insect Biochemistry and Physiology
Verified
Journal Article
Closed access
PDF file
ZAZahra Afrasiabi
Zahra Afrasiabi
HPHolly J.R. Popham
Holly J.R. Popham
DSDavid Stanley
David Stanley
DSDhananjay Suresh
Dhananjay Suresh
KFKristen Finley
Kristen Finley
AUAnandhi Upendran
Anandhi Upendran

8 February 2022 in Water
Verified
Journal Article
Open access
PDF file
TCTilak Chhetri
Tilak Chhetri
GCGary Cunningham
Gary Cunningham
DSDhananjay Suresh
Dhananjay Suresh
BSBruce Shanks
Bruce Shanks
RKRaghuraman Kannan
Raghuraman Kannan
ZAzahra afrasiabi
zahra afrasiabi
Modern agricultural activities and concentrated animal feeding operations (CAFOs) are two of the major sources of groundwater contamination that affect the quality of drinking water. Conventional water quality improvement methods include direct filtration, coagulation/settling treatment techniques, membrane-based systems, and absorption-based systems. However, to date, there are no efficient and cost-effective processes available for water treatment. This study developed an innovative nanotechnology-based technique to improve groundwater quality. Magnetic nanosponges (MNSs) were synthesized and characterized using two different magnetic nanoparticles along with polymeric coagulants. The efficiency of MNSs in removing pollutants in wastewater collected from local diary and swine CAFO lagoons was investigated. Standard water quality evaluation parameters, such as the total organic content (TOC), turbidity, total suspended solids (TSS), and biological oxygen demand (BOD), were measured prior to and after treatment with MNSs. The results demonstrate the potential of MNSs to improve the quality of groundwater and support the development of a cost-effective best management practice (BMP) that also employs traditional coagulants at CAFOs and other wastewater treatment plants.

14 March 2022 in Bioactive Materials
Verified
Journal Article
Open access
DSDhananjay Suresh
Dhananjay Suresh
ASAgasthya Suresh
Agasthya Suresh
RKRaghuraman Kannan
Raghuraman Kannan
The size of nanocarriers determines the biological property of the materials, especially as it relates to intratumoral distribution. Previous research has shown that sizes of 10–50 nm penetrate deep inside the tumor, resulting in better efficacy. On the other hand, studies have shown that gelatin exhibits excellent biological properties, including compatibility, degradability, and toxicity. Therefore, FDA approved gelatin as a safe material to use as an excipient in injectables. The bottleneck is the nonexistence of smaller-sized gelatin nanoparticles (GNPs) to realize the full potential of these biomaterials. Yet, GNPs with sizes of less than 50 nm have not been reported; the synthetic strategy reported in the literature uses “uncontrolled crosslinking coupled with nanoprecipitation”, resulting in larger particle size. We have developed a new method to self-assemble gelatin strands by using an anionic, phosphate-based crosslinker and controlled precipitation. The method we developed produced ultra-small gelatin nanoparticles (GX) of size 10 nm with a high degree of reproducibility, and it was characterized using dynamic light scattering (DLS), Energy-dispersive X-ray spectroscopy (EDS), High-resolution transmission, and scanning electron microscopy (HR-TEM/STEM). We also explored GX as a bioactive platform to encapsulate imaging and therapy agents within the cavity. Interestingly, we were able to encapsulate 2 nm size gold nanoparticles within the void of GX. The versatile nature of the GX particles was further demonstrated by surface functionalizing with larger size gelatin nanoparticles to form core-satellite nanocomposites. Additionally, we studied the tumor penetrability of dye-tagged 10, 50, and 200 nm gelatin nanoparticles. The study showed that smaller size gelatin nanoparticles penetrate deeper tumor regions than larger particles. In general, GX was efficient in penetrating the inner region of the spheroids. The results demonstrate the potential capabilities of ultra-small GX nanoparticles for multi-staged payload delivery, diagnostics, and cancer therapy.